Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  AbbVie    ABBV

ABBVIE (ABBV)
My previous session
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
08/07/2018 08/08/2018 08/09/2018 08/10/2018 08/14/2018 Date
94.06(c) 93.73(c) 95.47(c) 95.8(c) 96.21 Last
8 890 897 4 535 412 6 176 128 4 446 819 3 009 114 Volume
-3.09% -0.35% +1.86% +0.35% -0.59% Change
More quotes
Financials (USD)
Sales 2018 32 886 M
EBIT 2018 14 537 M
Net income 2018 10 366 M
Debt 2018 29 831 M
Yield 2018 3,81%
Sales 2019 34 535 M
EBIT 2019 16 166 M
Net income 2019 11 485 M
Debt 2019 26 153 M
Yield 2019 4,33%
P/E ratio 2018 14,54
P/E ratio 2019 12,50
EV / Sales2018 5,53x
EV / Sales2019 5,16x
Capitalization 152 B
More Financials
Company
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the discovery, development, manufacture and sale of a line of proprietary pharmaceutical products.It is focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology;... 
Sector
Pharmaceuticals
Calendar
10/26Earnings Release
More about the company
Surperformance© ratings of AbbVie
Trading Rating : Investor Rating :
More Ratings
Latest news on ABBVIE
08/13Pomerantz Law Firm Investigates Claims On Behalf of Investors of AbbVie Inc. ..
PR
08/09ABBVIE : Describes Findings in Alzheimer Disease (Pharmacokinetics, Safety, Tole..
AQ
08/09ABBVIE : Findings from AbbVie Has Provided New Data on Organic Research (Quantit..
AQ
08/08Merck's Zepatier price cut lands it co-exclusive status on Express Scripts 20..
AQ
08/07ABBVIE : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS..
AQ
07/31Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AbbVie Inc. (AB..
PR
07/31AbbVie Reports Second-Quarter 2018 Financial Results
AQ
07/28ABBVIE : posts 2Q profit, revenue beats on healthy sales of arthritis top-seller..
AQ
07/27ABBVIE : Citron, Options Players Predict A Drop For AbbVie
AQ
07/27ABBVIE INC. (NYSE : ABBV) Files An 8-K Results of Operations and Financial Condi..
AQ
More news
Sector news : Specialty & Advanced Pharmaceuticals
08:48aBAYER : Verdict In Weed Killer Case Hits Bayer -- WSJ
DJ
08:15aSHIRE PLC SHIRE PLC : Rule 2.9 Announcement
DJ
01:08aBIOGEN : pricey muscle drug Spinraza too costly for Britain
RE
08/13BAYER : Shares Plunge After Monsanto Weed Killer Ruling -- 3rd Update
DJ
08/13BAYER : Shares Plunge After Monsanto Weed Killer Ruling -- 2nd Update
DJ
More sector news : Specialty & Advanced Pharmaceuticals
MarketScreener Strategies on ABBVIE 
ABBVIE  - 2015
A likely recovery
BUY
More Strategies
Latest Tweets
04:12aSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Invest.. 
08/13ArQule's ARQ 531 shows encouraging action in preclinical studies; shares up 2.. 
08/13Accelerator Life Science Partners Launch Startup With $31 Million Series A: *.. 
08/12$ABBV $ARCC $AVGO $BBN $BUD $CVS $D $ENB $GBDC $GIS $HQH $JNJ $KHC $KYN $LMT .. 
08/11$VWORK $SFTBF $SFTBY $UBER $GOOG $GOOGL $EBAY $NPSND $NPSNY $FB $MSFT $TEAM $.. 
More tweets
Qtime:517
News from SeekingAlpha
08/13ArQule's ARQ 531 shows encouraging action in preclinical studies; shares up 2.. 
08/13DIVIDEND SENSEI'S PORTFOLIO UPDATE 4 : Overcoming Adversity And Soaring To New H.. 
08/12How To Retire Comfortably By 62 With A Million 
08/11VENTURE CAPITAL DEALS OF THE WEEK : SoftBank Hands WeWork $1B 
08/11STOCKS TO WATCH : Any Privacy For Tesla? 
Chart ABBVIE
Duration : Period :
AbbVie Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ABBVIE
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 109 $
Spread / Average Target 13%
EPS Revisions
Managers
NameTitle
Richard A. Gonzalez Chairman & Chief Executive Officer
Azita Saleki-Gerhardt Senior Vice President-Operations
William J. Chase Chief Financial Officer & Executive Vice President
Michael E. Severino Chief Scientific Officer & Executive VP
Robert J. Alpern Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ABBVIE-0.94%152 023
MERCK KGAA-0.72%13 377
KYOWA HAKKO KIRIN CO LTD-8.06%10 945
JAZZ PHARMACEUTICALS PLC30.24%10 715
ZHANGZHOU PIENTZEHUANG PHARMACEUTICL LTD69.37%9 156
CONVATEC GROUP2.68%5 166